跳至主要内容
临床试验/NCT04811079
NCT04811079已完成不适用

The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer

Johnson & Johnson Vision Care, Inc.2 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2021年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
2
主要终点
Visual Photosensitivity Threshold (VPT)

研究概览

简要总结

This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • The subject must read and sign the Informed Consent form.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • Healthy adult males or females age ≥18 and ≤30 years of age.
  • Normal color vision as measured using the Ishihara 38-plate test.
  • Normal stereopsis as measured by a suitable test.
  • Auto-refraction must show a spherical component of -2.00 through +2.00 D, and a cylindrical component of 0.00 through 1.50 D.
  • The subject's distance refractive sphere must be between -2.00 and +2.00 D in each eye.
  • The subject's distance refractive cylinder must be ≤ 1.50 D in each eye.
  • The subject must have unaided distance Snellen visual acuity of 20/200 or better for each eye.
  • The subject must have best corrected distance Snellen visual acuity of 20/25 or better for each eye.

排除标准

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
  • History of refractive surgery or other ocular surgery.
  • Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
  • Subjects that participated in the pilot study CR-
  • Systemic conditions or the use of medications that the investigator believes will contraindicate participation in this study.
  • Abnormal Level 3 neuro-ophthalmology exam including crystalline lens clarity Grade 3 or worse (Lens Opacities Classification System).
  • Any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA Slit Lamp Classification Scale.

结局指标

主要结局

Visual Photosensitivity Threshold (VPT)

时间窗: at approximately 2-week follow-up

VPT will measured via the SAOPA instrument. VPT is the point at which a sensation of pain or discomfort occurs when the intensity of light is gradually increased from a low level. Subject's discomfort responses will be indicated via a button press. Testing is complete when 10 response reversals are acquired.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验